| Advantages | Mouse lung organoids provide a physiologically relevant platform for studying lung development, modeling respiratory diseases (fibrosis, infection, cancer), and supporting preclinical drug discovery, toxicity testing, and regenerative medicine research. |
| Species | Mouse |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Lung |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They recapitulate key structural and functional features of the developing lung, including airway- and alveolar-like regions composed of epithelial, mesenchymal, and endothelial cell populations. These organoids express lineage-specific markers (NKX2.1, SPC, AQP5) and maintain genetic stability with reproducible differentiation. |
| Applications | Tissue-derived organoids are extensively applied in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By faithfully recapitulating disease states, these organoids provide a robust platform for evaluating patient-specific responses to novel compounds and guiding personalized treatment strategies. Moreover, they enable the development of innovative therapeutic approaches, particularly in cancer research and tissue regeneration, delivering precise experimental tools that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.